Reactive hepatitis in a patient with Crohn's disease successfully treated with infliximab: does tumor necrosis factor alpha play a role in reactive hepatitis?
Magro
F
F
Pereira
P
P
Carneiro
F
F
Veloso
F Tavarela
FT
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000502:physiology*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab